An updated overview of recent and ongoing deep brain stimulation (DBS) trials in patients with dementia: a systematic review

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Neurological Sciences

• Publication date

  2023-05-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10072-023-06821-wPMID 37204563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lecanemab: First Approval

  2023cited by this paper
• Effectiveness of Low-Frequency Pallidal Deep Brain Stimulation at 65 Hz in Tourette Syndrome.

  2021cited by this paper
• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

  2021cited by this paper
• Brain structures and networks responsible for stimulation‐induced memory flashbacks during forniceal deep brain stimulation for Alzheimer's disease

  2021cited by this paper
• Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action

  2021cited by this paper
• Aduhelm: The Best Hope for Alzheimer’s Disease Patients or the Worst Decision the FDA Has Ever Made?

  2021cited by this paper
• Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval

  2021cited by this paper
• Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer’s Disease

  2021cited by this paper
• Electrical stimulation of the nucleus basalis of meynert: a systematic review of preclinical and clinical data

  2021cited by this paper
• Characterization of Models for Identifying Physical and Cognitive Frailty in Older Adults With Diabetes: Systematic Review and Meta-Analysis

  2020cited by this paper
• Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson's disease dementia

  2020cited by this paper
• Late-onset vs nonmendelian early-onset Alzheimer disease

  2020cited by this paper
• Ethical considerations in deep brain stimulation for psychiatric illness.

  2020cited by this paper
• Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia

  2020cited by this paper
• Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial.

  2020cited by this paper
• Rate of Cognitive Decline in Alzheimer’s Disease Stratified by Age

  2019cited by this paper
• Partial improvement in performance of patients with severe Alzheimer's disease at an early stage of fornix deep brain stimulation

  2018cited by this paper
• Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer’s Disease

  2018cited by this paper
• Neuroanatomical Characteristics Associated With Response to Deep Brain Stimulation of the Nucleus Basalis of Meynert for Alzheimer's Disease

  2018cited by this paper
• Opening the debate on deep brain stimulation for Alzheimer disease – a critical evaluation of rationale, shortcomings, and ethical justification

  2018cited by this paper
• Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation

  2018cited by this paper
• Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations

  2018influential reference
• Chronic fornix deep brain stimulation in a transgenic Alzheimer’s rat model reduces amyloid burden, inflammation, and neuronal loss

  2018cited by this paper
• Precortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology

  2016cited by this paper
• Deep Brain Stimulation for Alzheimer’s Disease: Ethical Challenges for Clinical Research

  2016cited by this paper
• Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trial.

  2016cited by this paper
• A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer’s Disease

  2016cited by this paper
• Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease

  2015cited by this paper
• Deep brain stimulation for psychiatric disorders: where we are now.

  2015cited by this paper
• Deep brain stimulation for chronic pain.

  2015cited by this paper
• Changes in nutritional status after deep brain stimulation of the nucleus basalis of Meynert in Alzheimer's disease — Results of a phase I study

  2015cited by this paper
• Deep brain stimulation targeting the fornix for mild Alzheimer dementia: design of the ADvance randomized controlled trial

  2015cited by this paper
• Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease.

  2015cited by this paper
• The Present Indication and Future of Deep Brain Stimulation

  2015cited by this paper
• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

  2014cited by this paper
• An updated Alzheimer’s disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM

  2014cited by this paper
• Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature

  2014cited by this paper
• Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia

  2014cited by this paper
• Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia.

  2013cited by this paper
• Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease.

  2012cited by this paper
• Inclusion and exclusion criteria for DBS in dystonia

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Long‐term progression of Alzheimer's disease in patients under antidementia drugs

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use

  2011cited by this paper
• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

  2011cited by this paper
• Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

  2011cited by this paper
• A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease

  2010cited by this paper
• Deep brain stimulation for essential tremor: A systematic review

  2010cited by this paper
• Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice

  2010cited by this paper
• Disease progression meta‐analysis model in Alzheimer's disease

  2010cited by this paper
• Deep brain stimulation for the treatment of vegetative state

  2010cited by this paper
• Early-Onset Dementia Is Associated with Higher Mortality

  2008cited by this paper
• Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

  2006cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase

  1988cited by this paper
• Deep brain stimulation for chronic pain

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• No citing papers are available for this paper.